Connable Office Inc’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Connable Office Inc’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-476	Closed	-$7K	–	191
2019 Q4	$7K	Hold	476	–	–	﹤0.01%	179
2019 Q3	$7K	Hold	476	–	–	﹤0.01%	177
2019 Q2	$11K	Hold	476	–	–	﹤0.01%	180
2019 Q1	$33K	Hold	476	–	–	0.01%	170
2018 Q4	$25K	Hold	476	–	–	0.01%	154
2018 Q3	$32K	Hold	476	–	–	0.01%	175
2018 Q2	$56K	Hold	476	–	–	0.01%	171
2018 Q1	$39K	Buy	476 +79	+20%	+$8.96K	0.01%	171
2017 Q4	$59K	Hold	397	–	–	0.01%	174
2017 Q3	$25K	Hold	397	–	–	0.01%	171
2017 Q2	$19K	Hold	397	–	–	﹤0.01%	173
2017 Q1	$24K	Hold	397	–	–	0.01%	181
2016 Q4	$24K	Buy	+397	New	+$24.8K	0.01%	210

Other funds holding SRRA

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Connable Office Inc's SRRA Position: Q1 2020 in Review

Connable Office Inc sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q1 2020, closing a stake of 476 shares — an estimated $7K sold.

Connable Office Inc first reported a position in SRRA in Q4 2016 and held it in 13 quarters. The position peaked at $59K in Q4 2017. 22 funds tracked by Wall St. Rank hold SRRA as of Q1 2020.

Connable Office Inc reported no remaining Sierra Oncology, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Connable Office Inc sold 476 Sierra Oncology, Inc. Common Stock shares in Q1 2020, an estimated $7K.
Connable Office Inc first reported a position in Sierra Oncology, Inc. Common Stock in Q4 2016 and held it in 13 quarters.
Connable Office Inc's Sierra Oncology, Inc. Common Stock position peaked at $59K in Q4 2017.
22 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q1 2020.

Based on Connable Office Inc's 13F filing for Q1 2020, filed 8 May 2020.